Cargando…
Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study
There is an increasing interest for monitoring circulating myeloid-derived suppressor cells (MDSCs) in cancer patients, but there are also divergences in their phenotypic definition. To overcome this obstacle, the Cancer Immunoguiding Program under the umbrella of the Association of Cancer Immunothe...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4726716/ https://www.ncbi.nlm.nih.gov/pubmed/26728481 http://dx.doi.org/10.1007/s00262-015-1782-5 |
_version_ | 1782411873724923904 |
---|---|
author | Mandruzzato, Susanna Brandau, Sven Britten, Cedrik M. Bronte, Vincenzo Damuzzo, Vera Gouttefangeas, Cécile Maurer, Dominik Ottensmeier, Christian van der Burg, Sjoerd H. Welters, Marij J. P. Walter, Steffen |
author_facet | Mandruzzato, Susanna Brandau, Sven Britten, Cedrik M. Bronte, Vincenzo Damuzzo, Vera Gouttefangeas, Cécile Maurer, Dominik Ottensmeier, Christian van der Burg, Sjoerd H. Welters, Marij J. P. Walter, Steffen |
author_sort | Mandruzzato, Susanna |
collection | PubMed |
description | There is an increasing interest for monitoring circulating myeloid-derived suppressor cells (MDSCs) in cancer patients, but there are also divergences in their phenotypic definition. To overcome this obstacle, the Cancer Immunoguiding Program under the umbrella of the Association of Cancer Immunotherapy is coordinating a proficiency panel program that aims at harmonizing MDSC phenotyping. After a consultation period, a two-stage approach was designed to harmonize MDSC phenotype. In the first step, an international consortium of 23 laboratories immunophenotyped 10 putative MDSC subsets on pretested, peripheral blood mononuclear cells of healthy donors to assess the level of concordance and define robust marker combinations for the identification of circulating MDSCs. At this stage, no mandatory requirements to standardize reagents or protocols were introduced. Data analysis revealed a small intra-laboratory, but very high inter-laboratory variance for all MDSC subsets, especially for the granulocytic subsets. In particular, the use of a dead-cell marker altered significantly the reported percentage of granulocytic MDSCs, confirming that these cells are especially sensitive to cryopreservation and/or thawing. Importantly, the gating strategy was heterogeneous and associated with high inter-center variance. Overall, our results document the high variability in MDSC phenotyping in the multicenter setting if no harmonization/standardization measures are applied. Although the observed variability depended on a number of identified parameters, the main parameter associated with variation was the gating strategy. Based on these findings, we propose further efforts to harmonize marker combinations and gating parameters to identify strategies for a robust enumeration of MDSC subsets. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00262-015-1782-5) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4726716 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-47267162016-02-02 Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study Mandruzzato, Susanna Brandau, Sven Britten, Cedrik M. Bronte, Vincenzo Damuzzo, Vera Gouttefangeas, Cécile Maurer, Dominik Ottensmeier, Christian van der Burg, Sjoerd H. Welters, Marij J. P. Walter, Steffen Cancer Immunol Immunother Original Article There is an increasing interest for monitoring circulating myeloid-derived suppressor cells (MDSCs) in cancer patients, but there are also divergences in their phenotypic definition. To overcome this obstacle, the Cancer Immunoguiding Program under the umbrella of the Association of Cancer Immunotherapy is coordinating a proficiency panel program that aims at harmonizing MDSC phenotyping. After a consultation period, a two-stage approach was designed to harmonize MDSC phenotype. In the first step, an international consortium of 23 laboratories immunophenotyped 10 putative MDSC subsets on pretested, peripheral blood mononuclear cells of healthy donors to assess the level of concordance and define robust marker combinations for the identification of circulating MDSCs. At this stage, no mandatory requirements to standardize reagents or protocols were introduced. Data analysis revealed a small intra-laboratory, but very high inter-laboratory variance for all MDSC subsets, especially for the granulocytic subsets. In particular, the use of a dead-cell marker altered significantly the reported percentage of granulocytic MDSCs, confirming that these cells are especially sensitive to cryopreservation and/or thawing. Importantly, the gating strategy was heterogeneous and associated with high inter-center variance. Overall, our results document the high variability in MDSC phenotyping in the multicenter setting if no harmonization/standardization measures are applied. Although the observed variability depended on a number of identified parameters, the main parameter associated with variation was the gating strategy. Based on these findings, we propose further efforts to harmonize marker combinations and gating parameters to identify strategies for a robust enumeration of MDSC subsets. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00262-015-1782-5) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2016-01-04 2016 /pmc/articles/PMC4726716/ /pubmed/26728481 http://dx.doi.org/10.1007/s00262-015-1782-5 Text en © The Author(s) 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Article Mandruzzato, Susanna Brandau, Sven Britten, Cedrik M. Bronte, Vincenzo Damuzzo, Vera Gouttefangeas, Cécile Maurer, Dominik Ottensmeier, Christian van der Burg, Sjoerd H. Welters, Marij J. P. Walter, Steffen Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study |
title | Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study |
title_full | Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study |
title_fullStr | Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study |
title_full_unstemmed | Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study |
title_short | Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study |
title_sort | toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4726716/ https://www.ncbi.nlm.nih.gov/pubmed/26728481 http://dx.doi.org/10.1007/s00262-015-1782-5 |
work_keys_str_mv | AT mandruzzatosusanna towardharmonizedphenotypingofhumanmyeloidderivedsuppressorcellsbyflowcytometryresultsfromaninterimstudy AT brandausven towardharmonizedphenotypingofhumanmyeloidderivedsuppressorcellsbyflowcytometryresultsfromaninterimstudy AT brittencedrikm towardharmonizedphenotypingofhumanmyeloidderivedsuppressorcellsbyflowcytometryresultsfromaninterimstudy AT brontevincenzo towardharmonizedphenotypingofhumanmyeloidderivedsuppressorcellsbyflowcytometryresultsfromaninterimstudy AT damuzzovera towardharmonizedphenotypingofhumanmyeloidderivedsuppressorcellsbyflowcytometryresultsfromaninterimstudy AT gouttefangeascecile towardharmonizedphenotypingofhumanmyeloidderivedsuppressorcellsbyflowcytometryresultsfromaninterimstudy AT maurerdominik towardharmonizedphenotypingofhumanmyeloidderivedsuppressorcellsbyflowcytometryresultsfromaninterimstudy AT ottensmeierchristian towardharmonizedphenotypingofhumanmyeloidderivedsuppressorcellsbyflowcytometryresultsfromaninterimstudy AT vanderburgsjoerdh towardharmonizedphenotypingofhumanmyeloidderivedsuppressorcellsbyflowcytometryresultsfromaninterimstudy AT weltersmarijjp towardharmonizedphenotypingofhumanmyeloidderivedsuppressorcellsbyflowcytometryresultsfromaninterimstudy AT waltersteffen towardharmonizedphenotypingofhumanmyeloidderivedsuppressorcellsbyflowcytometryresultsfromaninterimstudy |